These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36903533)

  • 1. New, Low-Molecular Weight Chemical Compounds Inhibiting Biological Activity of Interleukin 15.
    Krzeczyński P; Dutkiewicz M; Zegrocka-Stendel O; Trzaskowski B; Koziak K
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore guided discovery of small-molecule interleukin 15 inhibitors.
    Żyżyńska-Granica B; Trzaskowski B; Niewieczerzał S; Filipek S; Zegrocka-Stendel O; Dutkiewicz M; Krzeczyński P; Kowalewska M; Koziak K
    Eur J Med Chem; 2017 Aug; 136():543-547. PubMed ID: 28535470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo.
    Wei Xq ; Orchardson M; Gracie JA; Leung BP; Gao Bm ; Guan H; Niedbala W; Paterson GK; McInnes IB; Liew FY
    J Immunol; 2001 Jul; 167(1):277-82. PubMed ID: 11418660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia.
    Chen J; Petrus M; Bamford R; Shih JH; Morris JC; Janik JE; Waldmann TA
    Blood; 2012 Jan; 119(1):137-43. PubMed ID: 22049515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of small molecule inhibitors of IL-15Rα using molecular docking and surface plasmon resonance technology].
    He Y; Wang HX; Liu M; Yang J; Sun ZL
    Sheng Li Xue Bao; 2023 Oct; 75(5):623-628. PubMed ID: 37909133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
    Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
    J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Targeting of IL-15Rα Is Sufficient to Reduce Inflammation.
    Meghnem D; Maillasson M; Barbieux I; Morisseau S; Keita D; Jacques Y; Quéméner A; Mortier E
    Front Immunol; 2022; 13():886213. PubMed ID: 35592318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
    Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
    Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation.
    Olsen SK; Ota N; Kishishita S; Kukimoto-Niino M; Murayama K; Uchiyama H; Toyama M; Terada T; Shirouzu M; Kanagawa O; Yokoyama S
    J Biol Chem; 2007 Dec; 282(51):37191-204. PubMed ID: 17947230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
    Votavova P; Tomala J; Kovar M
    Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-inflammatory potential of cefazolin as common gamma chain cytokine inhibitor.
    Żyżyńska-Granica B; Trzaskowski B; Dutkiewicz M; Zegrocka-Stendel O; Machcińska M; Bocian K; Kowalewska M; Koziak K
    Sci Rep; 2020 Feb; 10(1):2886. PubMed ID: 32076052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a potent anti-IL-15 antibody with opposing mechanisms of action in vitro and in vivo.
    Finch DK; Midha A; Buchanan CL; Cochrane D; Craggs RI; Cruwys S; Grahames C; Kolbeck R; Lowe DC; Maltby J; Pattison DV; Vousden KA; Ward A; Sleeman MA; Mallinder PR
    Br J Pharmacol; 2011 Jan; 162(2):480-90. PubMed ID: 20942844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer.
    Badoual C; Bouchaud G; Agueznay Nel H; Mortier E; Hans S; Gey A; Fernani F; Peyrard S; -Puig PL; Bruneval P; Sastre X; Plet A; Garrigue-Antar L; Quintin-Colonna F; Fridman WH; Brasnu D; Jacques Y; Tartour E
    Cancer Res; 2008 May; 68(10):3907-14. PubMed ID: 18483276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational modification, synthesis and biological evaluation of N-substituted phthalazinone derivatives designed to target interleukine-15 protein.
    Smadja J; Quéméner A; Maillasson M; Sicard B; Leray A; Arzel L; Lebreton J; Mortier E; Dubreuil D; Mathé-Allainmat M
    Bioorg Med Chem; 2021 Jun; 39():116161. PubMed ID: 33932805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of the interleukin-15 binding site on its alpha receptor by NMR.
    Hanick NA; Rickert M; Varani L; Bankovich AJ; Cochran JR; Kim DM; Surh CD; Garcia KC
    Biochemistry; 2007 Aug; 46(33):9453-61. PubMed ID: 17655329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice.
    Shi Y; Dincheva-Vogel L; Ayemoba CE; Fung JP; Bergamaschi C; Pavlakis GN; Farzaneh F; Gaensler KML
    Blood Adv; 2018 Nov; 2(22):3177-3192. PubMed ID: 30482760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective reduction of post-selection CD8 thymocyte proliferation in IL-15Rα deficient mice.
    Chow KP; Qiu JT; Lee JM; Hsu SL; Yang SC; Wu NN; Huang W; Wu TS
    PLoS One; 2012; 7(3):e33152. PubMed ID: 22448237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-15R alpha chain signals through association with Syk in human B cells.
    Bulanova E; Budagian V; Pohl T; Krause H; Dürkop H; Paus R; Bulfone-Paus S
    J Immunol; 2001 Dec; 167(11):6292-302. PubMed ID: 11714793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the IL-15-IL-15Ralpha complex, a cytokine-receptor unit presented in trans.
    Chirifu M; Hayashi C; Nakamura T; Toma S; Shuto T; Kai H; Yamagata Y; Davis SJ; Ikemizu S
    Nat Immunol; 2007 Sep; 8(9):1001-7. PubMed ID: 17643103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity.
    Bergamaschi C; Rosati M; Jalah R; Valentin A; Kulkarni V; Alicea C; Zhang GM; Patel V; Felber BK; Pavlakis GN
    J Biol Chem; 2008 Feb; 283(7):4189-99. PubMed ID: 18055460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.